These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30842751)

  • 21. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study.
    Wahlund LO; Julin P; Johansson SE; Scheltens P
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):630-5. PubMed ID: 11032615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
    Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain atrophy pattern in patients with mild cognitive impairment: MRI study.
    Calandrelli R; Panfili M; Onofrj V; Tran HE; Piludu F; Guglielmi V; Colosimo C; Pilato F
    Transl Neurosci; 2022 Jan; 13(1):335-348. PubMed ID: 36250040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The usefulness of visual rating of posterior atrophy in predicting rapid cognitive decline in Alzheimer disease: A preliminary study.
    Suh J; Park YH; Kim HR; Jang JW; Kang MJ; Yang J; Baek MJ; Kim S
    Int J Geriatr Psychiatry; 2019 Apr; 34(4):625-632. PubMed ID: 30714196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristic asymmetric limbic and anterior temporal atrophy in demented patients with pathologically confirmed argyrophilic grain disease.
    Sakurai K; Tokumaru AM; Ikeda T; Morimoto S; Inui S; Sumida K; Oba H; Nakagawa M; Matsukawa N; Hashizume Y
    Neuroradiology; 2019 Nov; 61(11):1239-1249. PubMed ID: 31256221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural MRI discriminates individuals with Mild Cognitive Impairment from age-matched controls: a combined neuropsychological and voxel based morphometry study.
    Trivedi MA; Wichmann AK; Torgerson BM; Ward MA; Schmitz TW; Ries ML; Koscik RL; Asthana S; Johnson SC
    Alzheimers Dement; 2006 Oct; 2(4):296-302. PubMed ID: 19020671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease.
    Rodriguez MJ; Potter E; Shen Q; Barker W; Greig-Custo M; Agron J; Loewenstein D; Duara R
    Alzheimers Dement; 2012 May; 8(3):211-8. PubMed ID: 22546353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
    Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein HC; Vermersch P; Kuiper M; Steinling M; Wolters EC; Valk J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):967-72. PubMed ID: 1431963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort.
    Loreto F; Gontsarova A; Scott G; Patel N; Win Z; Carswell C; Perry R; Malhotra P
    Ann Clin Transl Neurol; 2023 Apr; 10(4):619-631. PubMed ID: 36872523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis.
    Rhodius-Meester HFM; Benedictus MR; Wattjes MP; Barkhof F; Scheltens P; Muller M; van der Flier WM
    Front Aging Neurosci; 2017; 9():117. PubMed ID: 28536518
    [No Abstract]   [Full Text] [Related]  

  • 39. Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementia.
    Pleizier CM; van der Vlies AE; Koedam E; Koene T; Barkhof F; van der Flier WM; Scheltens P; Pijnenburg Y
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1145-8. PubMed ID: 22933816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale.
    Cho H; Kwon JH; Seo HJ
    Arch Gerontol Geriatr; 2009; 48(3):415-8. PubMed ID: 18468705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.